Navigation Links
Protox Announces Positive Clinical Data from Prostate Cancer Study

ncouraging signs of therapeutic activity were observed.

No significant safety issues relating to PRX302 treatment were encountered in this clinical trial. One patient in the study, who met inclusion criteria in spite of having borderline liver abnormalities, showed a transient rise in liver enzymes (Grade 3 on the National Cancer Institute's 5-stage grading scale) that quickly returned to screening levels. An expanded cohort was enrolled at this dose in order to collect additional safety data. No safety issues were observed in any patients within the expanded cohort or in further cohorts that received higher doses. In summary, no serious adverse events were reported relating to PRX302 and all other adverse events reported were mostly associated with the injection procedure, rating no higher than Grade 1 (mild).

Assessment of potential therapeutic activity was determined by measuring PSA levels throughout the study and conducting prostate biopsies at 30 days post-treatment. PSA is one of the most widely recognized disease markers in prostate cancer and levels of PSA in the blood are used in the diagnosis of prostate cancer, monitoring cancer progression and tracking patient responses to its treatment.

A comparison of prostate biopsies taken at baseline and at 30 days post-treatment shows that 18 of the 24 patients tested in this trial had a decrease in the percentage of cancer-positive biopsies. Three of the patients showed a complete absence of cancer in their day 30 biopsy.

Two specific measurement indicators, PSA doubling time (PSADT) and PSA velocity (PSAV), are key parameters in predicting clinical progression, metastasis and mortality in patients with prostate cancer. Of the 24 patients tested in this study, 90 day PSA data is available for 15 patients at this time. Comparison of PSA levels pre- and post-treatment shows a clear and desirable trend towards an incr
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:8/21/2014)... Aug. 21, 2014   Auxilium Pharmaceuticals, Inc. ... biopharmaceutical company, today announced positive results from a ... histolyticum (or CCH) for the treatment of edematous ... the Phase 2a trial, all three doses of ... showed an improvement in the appearance of cellulite ...
(Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Indiana blocked the sale of ...
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... (NADDI) today lauded the latest results achieved by ... system, known as the National Precursor Log Exchange ... law enforcement officials track down meth offenders and ... technology in Kansas blocked ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
(Date:8/22/2014)... August 22, 2014 Drug and ... Over the years, substance abuse has claimed thousands of ... Brunswick, OH is providing hope for teenagers who are ... Brunswick helpline is designed to provide adolescents and their ... to find the best youth rehab facility to meet ...
(Date:8/22/2014)... Carolina Senior Living Apartments, owned and ... ), recently opened 30 spacious one-bedroom affordable residential ... resources in Lexington, NC. Each unit is equipped ... controlled heating and cooling system, and secured entry. ... consists of a three-story building with an elevator ...
(Date:8/21/2014)... August 22, 2014 Strongly influenced ... overcompensated, even when there are no consequences, researchers ... have found. , This could imply that humans ... inequity of others, researchers said. Their findings are ... suggest humans’ sense of unfairness is affected by ...
(Date:8/21/2014)... 2014 Recently, Skmen.com, a distinguished garment supplier, ... girls’ casual dresses . From today until August ... 30 percent off) when they are shopping at the company’s ... outfits are according to the newest quality standards; they are ... charming casual dresses, worldwide ladies can also access the other ...
(Date:8/21/2014)... DoudouneCanadienneGoosePasCher.fr, one of the most popular ... unveiled its new selection of Trillium Parkas for 2014. ... all these fashionable and comfortable items are available at ... will last until September 01. , The CEO ... Canada Goose Trillium Parkas for new and ...
Breaking Medicine News(10 mins):Health News:Substance Abuse Helpline Provides Hope for Teens & Parents in Brunswick, OH 2Health News:United Church Homes and Services Announce New Affordable Housing Community for Seniors 2Health News:Influenced by Self-Interest, Humans Less Concerned About Inequity To Others, Researchers Find 2Health News:Influenced by Self-Interest, Humans Less Concerned About Inequity To Others, Researchers Find 3Health News:Charming Girls’ Casual Dresses Now Released by Distinguished Garment Company Skmen.com 2Health News:Fashionable And Comfortable Canada Goose Trillium Parkas For Sale At DoudouneCanadienneGoosePasCher.fr 2
... HealthDay Reporter , THURSDAY, April 12 (HealthDay News) ... were seized by Australian customs officials revealed that many ... have produced allergic or even toxic reactions among consumers. ... some of the medicines also contained animal parts from ...
... (HealthDay News) -- A new study finds that obesity accounts ... is more than twice as high as previous estimates. ... obesity, said the researchers from Cornell University in Ithaca, N.Y. ... are $2,741 a year higher (in 2005 dollars) than if ...
... of pediatrics at Women & Infants Hospital of Rhode Island ... recently inducted into the Legends of Neonatology Hall of Fame ... of two physicians inducted this year for contributions to the ... Dr. Oh will also receive another prestigious award, the Maureen ...
... , THURSDAY, April 12 (HealthDay News) -- Toddlers are ... other toddlers doing it, a new study shows. Researchers found ... saw it repeated by three other toddlers than if they saw ... appear online April 12 in the journal Current Biology . ...
... first of its kind study conducted by researchers at ... that one fall requiring first responder emergency medical services ... Boston Logan International Airport, with 37 percent of those ... was done at the request of the Massachusetts Port ...
... News) -- People who have Huntington,s disease are much less ... according to a new study that suggests the diseases share ... those with Huntington,s had a 53 percent lower risk of ... Besides Huntington,s disease, the lower cancer risk applies to ...
Cached Medicine News:Health News:DNA Testing Finds Allergens, Toxins in Traditional Chinese Medicines 2Health News:DNA Testing Finds Allergens, Toxins in Traditional Chinese Medicines 3Health News:DNA Testing Finds Allergens, Toxins in Traditional Chinese Medicines 4Health News:Dr. William Oh named 2012 Legend of Neonatology 2Health News:BMC study shows diverting passengers to elevators could help reduce falls at Logan Airport 2Health News:Huntington's Disease Linked to Reduced Cancer Risk in Study 2
... one step fixation of soft tissue to bone. ... cuff repair in one simple insertion maneuver. The ... of 5 mm and a small 2 mm ... hold a thin, bioabsorbable PLLA disc 5 mm ...
... bioabsorbable push-in suture anchor with a molded-in suture ... in the shoulder joint and other indications where ... is required. The exclusive braided suture eyelet loop ... and provides superior resistance to suture abrasion compared ...
TigerStick is a white #2 FiberStick with black stripes and a stiffened, 12 inch, waxed end. It is especially useful when motion determination and alternating colored sutures are required in the arthr...
... Flowmaster. It is a new portable digital flowmeter ... of use, simplicity and cost effectiveness are top ... now very easy to give a patient some ... and data will be send wirelessly to the ...
Medicine Products: